Extensive right coronary artery thrombosis in a patient with COVID-19: A case report

Clarissa Campo Dall'Orto1, Rubens Pierry Ferreira Lopes2, Mariana Torres Cancela3

  • 1Therapy Center, Brazilian Society of Health Support Hospital, Teixeira de Freitas 45987-088, Bahia, Brazil. clarissadallorto@alumni.usp.br.

Insights

This case study details the first reported instance of right coronary artery thrombosis in a patient with coronavirus disease 2019 (COVID-19). Dual antiplatelet and anticoagulation therapy successfully resolved the extensive thrombi.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Cardiovascular complications are frequent in hospitalized coronavirus disease 2019 (COVID-19) patients, contributing to significant morbidity and mortality.
  • Right coronary artery (RCA) thrombosis is a rare but serious complication associated with COVID-19.

Observation:

  • A 62-year-old female with COVID-19 presented with symptoms of myocardial infarction, including chest pain and ST-segment elevations.
  • Intracoronary imaging (intravascular ultrasound and optical coherence tomography) revealed extensive subacute and acute thrombi in the RCA and its branches, alongside underlying atherosclerosis.
  • Invasive physiological assessment using the resting full-cycle ratio showed no significant impairment in coronary flow despite the presence of plaque.

Findings:

  • This is the first documented case of extensive RCA thrombosis in a COVID-19 patient, comprehensively evaluated with intracoronary imaging and physiology.
  • Dual antiplatelet and anticoagulation therapy led to complete resolution of the coronary thrombi within 7 days.
  • The patient remained asymptomatic during a 6-month follow-up period.

Implications:

  • This case highlights the potential for severe thrombotic events in the coronary arteries of COVID-19 patients.
  • Effective management of COVID-19-associated coronary thrombosis can be achieved with timely dual antiplatelet and anticoagulation therapy.
  • Further research is warranted to understand the mechanisms and long-term cardiovascular impact of COVID-19 on coronary vasculature.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
18
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23